Title : The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.

Pub. Date : 2011 May

PMID : 21463117






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dasatinib is a kinase inhibitor that inhibits BCR-ABL, Src family kinases, c-Kit, and platelet-derived growth factor receptor kinase. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Potential targets for dasatinib in chronic lymphocytic leukemia (CLL) include Lyn (a Src family kinase), ABL, and the associated CD40 pathway. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens